Tag: FS2

BirchBioMed reports positive results for keloid scars candidate FS2 in phase 2 trial

pharmanewsdaily- January 23, 2021

BirchBioMed has reported positive results from a phase 2 trial evaluating the use of topical FS2, the company’s antifibrotic platform therapy, in the treatment of ... Read More